PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
87.59%
Net income growth above 1.5x ORCL's 6.83%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
21.92%
D&A growth well above ORCL's 5.22%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
289.75%
Some yoy growth while ORCL is negative at -327.27%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-26.54%
Negative yoy SBC while ORCL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
1010.55%
Well above ORCL's 102.63% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
149.41%
AR growth of 149.41% while ORCL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1135.03%
Growth well above ORCL's 102.63%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-1826.51%
Both negative yoy, with ORCL at -18.40%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
257.05%
Operating cash flow growth at 50-75% of ORCL's 492.18%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
19.41%
Some CapEx rise while ORCL is negative at -35.09%. John Neff would see competitor possibly building capacity while we hold back expansions.
67.20%
Some acquisitions while ORCL is negative at -585.17%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
20.27%
Less growth in investment purchases vs. ORCL's 76.11%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-9.36%
We reduce yoy sales while ORCL is 56.79%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
134.12%
Growth of 134.12% while ORCL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
126.10%
Investing outflow well above ORCL's 123.66%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-82.38%
Both yoy lines negative, with ORCL at -70.79%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-18.65%
We cut yoy buybacks while ORCL is 0.30%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.